Giorgia Gurioli

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 27, 2026

Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.

Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.

Journal: Oncogene

Published: May 15, 2026

Correction: Endometrioid cancer associated with endometriosis: from the seed and soil theory to clinical practice.

Correction: Endometrioid cancer associated with endometriosis: from the seed and soil theory to clinical practice.

Journal: Frontiers in oncology

Published: April 28, 2026

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 19, 2026

Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Journal: Prostate cancer and prostatic diseases

Published: October 16, 2025

Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 09, 2025

Risk of myelodysplastic syndrome and acute myeloid leukemia related to PARP inhibitor maintenance line in real-world ovarian cancer patients.

Risk of myelodysplastic syndrome and acute myeloid leukemia related to PARP inhibitor maintenance line in real-world ovarian cancer patients.

Journal: The oncologist

Published: December 07, 2024

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA.

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA.

Journal: Scientific reports

Published: December 05, 2024

Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.

Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.

Journal: ESMO open

Published: September 11, 2024

The use of platelets as a clinical tool in oncology: opportunities and challenges.

The use of platelets as a clinical tool in oncology: opportunities and challenges.

Journal: Cancer letters

Published: February 16, 2024

Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study.

Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study.

Journal: iScience

Published: February 06, 2024

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.

Journal: European urology open science

Published: January 25, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026